The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis.
Journal Information
Full Title: Allergy Asthma Clin Immunol
Abbreviation: Allergy Asthma Clin Immunol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateUVA IRB-HSR 23337. Consent for publicationNot applicable. Competing interestsNone of the authors have any competing interests to declare. Competing interests None of the authors have any competing interests to declare."
Funding Disclosure
Evidence found in paper:
"Funding Larry Borish receives salary support from NIH: UO1 AI123337, R21 AI151496, and R56 AI158519."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025